← Leaderboards
Tania France Gendron
Mayo Clinic Jacksonville
$4,632,093
Attributed
$8,067,739
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,067,739 · 5
By mechanism
R01$6,250,265 · 2
P01$969,575 · 1
R21$847,899 · 2
Top collaborators
- Marka Van Blitterswijk5 shared
- Yongjie Zhang4 shared
- Kevin Boylan2 shared
- Ke Zhang1 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Leonard Petrucelli$43,938,031
- Kevin Boylan$2,850,878
- Bjorn E Oskarsson$14,441,633
- Yongjie Zhang$2,227,470
- Marka Van Blitterswijk$6,748,882
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesC9orf72TissuesProteinsAutopsyProtein Tdp-43PathologyMolecularBrain TissueNew Therapeutic TargetPlayInvestigationClinical TrialsBrainAmyotrophic Lateral SclerosisGeneticNerve DegenerationNeurodegenerative DisordersEffective TherapyPathogenesisDiagnosisEvaluationBiological MarkersInsight
Grant awards (18)
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2025 · NS
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins$582,485
R01 · FY2025 · NS
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2024 · NS
Core C$189,250
P01 · FY2024 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2023 · NS
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins$582,485
R01 · FY2023 · NS
Core C$203,450
P01 · FY2023 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2022 · NS
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins$582,485
R01 · FY2022 · NS
Core C$169,975
P01 · FY2022 · NS · contact PI
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insight$780,935
R01 · FY2021 · NS
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteins$598,135
R01 · FY2021 · NS
Core C$203,450
P01 · FY2021 · NS · contact PI
Core C$203,450
P01 · FY2020 · NS · contact PI
c9RAN proteins as a biomarker for C9ORF72-associated ALS and FTD$191,275
R21 · FY2015 · NS · contact PI
c9RAN proteins as a biomarker for C9ORF72-associated ALS and FTD$230,374
R21 · FY2014 · NS · contact PI
Pathologically modified TDP-43 in neurodegenerative diseases$193,750
R21 · FY2012 · NS · contact PI
Pathologically modified TDP-43 in neurodegenerative diseases$232,500
R21 · FY2011 · NS · contact PI